Cystic Fibrosis Research Today is a free monthly online journal that collates and summarizes the latest research about Cystic Fibrosis, including details on symptoms, genetics, treatment, information.

Volume 6 (2009), Issue 8 (August)

1. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.
   PLoS Genet, 5(7): e1000586. [Abstract] [Full-text]
2. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
   Int J Antimicrob Agents, 34(4): 370-4. [Abstract] [Full-text]
3. Pain in children and adults with cystic fibrosis: a comparative study.
   J Pain Symptom Manage, 38(2): 281-90. [Abstract] [Full-text]
4. Update on cystic fibrosis-related bone disease: a special focus on children.
   Paediatr Respir Rev, 10(3): 134-42. [Abstract] [Full-text]
5. Genetics terminology for respiratory physicians.
   Paediatr Respir Rev, 10(3): 124-33. [Abstract] [Full-text]
6. Cystic fibrosis related diabetes.
   Paediatr Respir Rev, 10(3): 118-23; quiz 123. [Abstract] [Full-text]
7. Exercise and physical activity in children with cystic fibrosis.
   Paediatr Respir Rev, 10(3): 105-9. [Abstract] [Full-text]
8. Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia.
   Appl Environ Microbiol, 75(16): 5250-60. [Abstract] [Full-text]
9. Clinical exercise testing in children and adolescents with cystic fibrosis.
   Pediatr Phys Ther, 21(3): 275-81. [Abstract] [Full-text]
10. CFTR regulation of intracellular pH and ceramides is required for lung endothelial cell apoptosis.
    Am J Respir Cell Mol Biol, 41(3): 314-23. [Abstract] [Full-text]
11. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis.
    Am J Respir Cell Mol Biol, 41(3): 367-75. [Abstract] [Full-text]
12. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.
    Am J Respir Cell Mol Biol, 41(3): 305-13. [Abstract] [Full-text]
13. The reliability of lung crackle characteristics in cystic fibrosis and bronchiectasis patients in a clinical setting.
    Physiol Meas, 30(9): 903-12. [Abstract] [Full-text]
14. Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis.
    Am J Clin Nutr, 90(3): 477-84. [Abstract] [Full-text]
15. Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs.
    J Pediatr Psychol, 34(8): 893-902. [Abstract] [Full-text]
16. Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.
    Radiology, 252(2): 534-43. [Abstract] [Full-text]
17. Tracheomalacia in adults with cystic fibrosis: determination of prevalence and severity with dynamic cine CT.
    Radiology, 252(2): 577-86. [Abstract] [Full-text]
18. Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian study.
    J Pediatr Gastroenterol Nutr, 49(3): 335-42. [Abstract] [Full-text]
19. Influence of the duplication of CFTR exon 9 and its flanking sequences on diagnosis of cystic fibrosis mutations.
    J Mol Diagn, 11(5): 488-93. [Abstract] [Full-text]
20. Specific inhibition of epithelial Na+ channels by antisense oligonucleotides for the treatment of Na+ hyperabsorption in cystic fibrosis.
    J Gene Med, 11(9): 813-23. [Abstract] [Full-text]
21. Outcomes of sinus surgery in adults with cystic fibrosis.
    Otolaryngol Head Neck Surg, 141(3): 358-63. [Abstract] [Full-text]
22. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.
    Diabetes Care, 32(9): 1626-31. [Abstract] [Full-text]

© 2004-2010 Cystic Fibrosis Research Today. All Rights Reserved.